PubRank

Leigh C Murphy

Author PubWeight™ 42.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Prohibitins: emerging roles in diverse functions. J Cell Mol Med 2006 1.81
2 Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression. Clin Cancer Res 2002 1.71
3 Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res 2003 1.67
4 Prohibitin: a potential target for new therapeutics. Trends Mol Med 2005 1.60
5 Targeting the EGFR pathway for cancer therapy. Curr Med Chem 2006 1.48
6 S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol 2004 1.37
7 Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. Clin Cancer Res 2003 1.23
8 Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res 2003 1.20
9 Influence of evolution in tumor biobanking on the interpretation of translational research. Cancer Epidemiol Biomarkers Prev 2008 1.15
10 The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer. Cancer Res 2005 1.15
11 S100A7 and the progression of breast cancer. Breast Cancer Res 2004 1.14
12 Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium. Cancer Res 2002 1.10
13 Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides. Nucleic Acids Res 2009 1.07
14 Estrogen receptor-alpha phosphorylated at Ser118 is present at the promoters of estrogen-regulated genes and is not altered due to HER-2 overexpression. Cancer Res 2006 1.05
15 Identification of new human coding steroid receptor RNA activator isoforms. Biochem Biophys Res Commun 2003 1.04
16 S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast. Breast Cancer Res 2004 1.04
17 Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas. Breast Cancer Res Treat 2008 1.03
18 Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma. Clin Cancer Res 2004 1.03
19 Analysis of gene expression in ductal carcinoma in situ of the breast. Clin Cancer Res 2002 1.01
20 Assay development for the determination of phosphorylation stoichiometry using multiple reaction monitoring methods with and without phosphatase treatment: application to breast cancer signaling pathways. Anal Chem 2010 1.00
21 Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target. J Steroid Biochem Mol Biol 2007 0.98
22 Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype. Virchows Arch 2009 0.96
23 Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer. Breast Cancer Res Treat 2006 0.94
24 RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer. BMC Cancer 2002 0.93
25 Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. BMC Cancer 2005 0.92
26 A phosphorylation code for oestrogen receptor-alpha predicts clinical outcome to endocrine therapy in breast cancer. Endocr Relat Cancer 2010 0.92
27 Assessment of multiple different estrogen receptor-beta antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions. Breast Cancer Res Treat 2006 0.90
28 A bi-faceted role of estrogen receptor β in breast cancer. Endocr Relat Cancer 2013 0.89
29 Relationship between mammaglobin expression and estrogen receptor status in breast tumors. Endocrine 2003 0.88
30 Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients. Breast Cancer Res 2009 0.88
31 Differential expression and comparative subcellular localization of estrogen receptor beta isoforms in virally transformed and normal cultured human lens epithelial cells. Exp Eye Res 2005 0.87
32 Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha. Breast Cancer Res Treat 2008 0.87
33 Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors. Mol Cell Biochem 2007 0.86
34 Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer. Endocr Relat Cancer 2012 0.86
35 ERβ splice variant expression in four large cohorts of human breast cancer patient tumors. Breast Cancer Res Treat 2014 0.85
36 Claudin 1 expression in basal-like breast cancer is related to patient age. BMC Cancer 2013 0.84
37 S100A7 (psoriasin) influences immune response genes in human breast cancer. Exp Cell Res 2007 0.82
38 Steroid receptor RNA activator protein (SRAP) expression as a prognostic factor in ER+ human breast tumors. J Cancer Res Clin Oncol 2013 0.80
39 Estrogen receptor alpha phosphorylated at tyrosine 537 is associated with poor clinical outcome in breast cancer patients treated with tamoxifen. Horm Cancer 2010 0.78
40 Targeted production of proprotein convertase PC1 enhances mammary development and tumorigenesis in transgenic mice. Can J Physiol Pharmacol 2009 0.76